METTL14 promoted MDS development by enhancing the m6A modification of SETBP1 mRNA through formation of METTL3-METTL14 complex, leading to increased stability and expression of SETBP1 mRNA. The gene discussed is METTL14; the disease is myelodysplastic syndrome.